Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response, was established to aid in securing our nation from chemical, biological, radiological, and nuclear (CBRN) threats, as well as from pandemic influenza (PI) and emerging infectious diseases (EID).
Subsidy: no max.
Funding rate: 100%
Project duration: max. 5 years; project specific
Consortium: Applicants can be from any country. Applicants may include single entities or teams from private sector organizations, government laboratories, and academic institutions.
Scope: Support advanced development activities of medical countermeasures for influenza and other emerging respiratory viruses to be specified by BARDA. BARDA is also prioritizing broadly reactive immunotherapeutics, such as monoclonal antibodies, that will be effective in treating severely ill, hospitalized patients of all ages who are infected with influenza or other emerging infectious diseases.
To get free funding updates, including BARDA, subscribe to Catalyze Alerts.
BARDA supports the transition of medical countermeasures such as vaccines, drugs, and diagnostics from research through advanced development towards consideration for approval by the FDA and inclusion into the Strategic National Stockpile. BARDA’s support includes funding, technical assistance and core services, ranging from a clinical research organization network to Centers for Innovation in Advanced Development and Manufacturing, and a fill-finish manufacturing network. To-date, BARDA has supported 42 FDA approvals for products addressing CBRN, PI, and EID threats. Visit the SNN website for more information.
BARDAs mission is accomplished through successful public-private partnerships with industry to share risk, improve efficiency and accelerate development all while sustaining a marketplace that guarantees continued access to countermeasures vital to their national security.
Visit the website for more information
Get funding, make impact
Whether you’re an academic or entrepreneur, we craft the roadmap you need to take on the challenges present in finding funding and reaching your market. With over 10 years of experience, we are your gateway to European funding, and beyond.
- Fund. What if funding wasn’t a barrier to innovation? We guide you through the way of finding and obtaining funds.
- Grow. What if your journey was clear? Get the best support for your grant journey.
- Manage. What if you only had to focus on R&D? We provide the support you need to get your innovation on the market.